dabigatran has been researched along with Vascular Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, H; Mushahid, H; Shah, SA | 1 |
| Agrawal, A; Bhardwaj, A; Bharti, JN; Rajan M, B | 1 |
| Chantrathammachart, P; Hebbel, RP; Key, NS; Mackman, N; Mickelson, J; Monroe, DM; Pawlinski, R; Sparkenbaugh, EM; van Ryn, J | 1 |
| Aghi, A; Arcidiacono, MV; Dalle Carbonare, L; Dusso, A; Fusaro, M; Gallieni, M; Pasho, S; Valenti, MT | 1 |
4 other study(ies) available for dabigatran and Vascular Diseases
| Article | Year |
|---|---|
Dabigatran for venous malformations: A call for a stringent approach.
Topics: Dabigatran; Humans; Vascular Diseases; Vascular Malformations | 2023 |
A novel use of intermittent low dose dabigatran for maintenance of remission in livedoid vasculopathy.
Topics: Dabigatran; Humans; Livedo Reticularis; Vascular Diseases | 2021 |
Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease.
Topics: Anemia, Sickle Cell; Animals; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Bone Marrow Transplantation; Dabigatran; Disease Models, Animal; Factor Xa; Factor Xa Inhibitors; Female; Immunoenzyme Techniques; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Receptor, PAR-1; Receptor, PAR-2; Rivaroxaban; Thiophenes; Thrombin; Vascular Diseases | 2014 |
Differential Effects of Dabigatran and Warfarin on Bone Volume and Structure in Rats with Normal Renal Function.
Topics: Animals; Anticoagulants; Antithrombins; Aorta; Bone and Bones; Bone Diseases, Metabolic; Bone Remodeling; Calcinosis; Dabigatran; Female; Fractures, Spontaneous; Iliac Artery; Kidney; Minerals; Osteoblasts; Osteoclasts; Random Allocation; Rats; Rats, Sprague-Dawley; Vascular Diseases; Vitamin K; Warfarin | 2015 |